Florida Cancer Specialists & Research Institute

Michael Diaz, MD, president & managing physician of Florida Cancer Specialists & Research Institute, was announced as the recipient of the Florida Society of Clinical Oncology Dorothy Green Phillips Legacy Award 2022.

Nathan H. Walcker, MBA, chief executive officer, Florida Cancer Specialists & Research Institute (FCSRI), discusses what guests can expect at the in-person Tampa meeting of The American Journal of Managed Care®'s Institute for Value-Based Medicine® (IVBM), co-hosted by FCSRI.

Michael Diaz, MD, president and managing physician, Florida Cancer Specialists & Research Institute, previews the Tampa meeting of The American Journal of Managed Care®'s Institute for Value-Based Medicine® (IVBM), cohosted by Florida Cancer Specialists & Research Institute.

The frequency of global crises such as hurricanes, war, and the pandemic makes a standing committee necessary.

Florida Cancer Specialists & Research Institute (FCS) was ranked at the top among the 126 oncology practices participating in the Oncology Care Model across the country.

The shift to a value-based care platform through the Oncology Care Model was shown to stimulate a cost-effective, value-based platform for care delivery for FCS patients.

A recently published case study by Florida Cancer Specialists & Research Institute showcased the practice’s multi-year track record of delivering savings as a participant in the Oncology Care Model (OCM) when compared with OCM and non-OCM practices nationally.

Michael Diaz, MD, president and managing physician, Florida Cancer Specialists & Research Institute, speaks on takeaways from his discussions on site of care and pharmacy benefit managers (PBMs) at the 2022 Community Oncology Conference.

A Florida Cancer Specialists physician led a discussion on Hodgkin lymphoma as a part of the 2022 Leukemia and Lymphoma Society’s Blood Cancer Conference.

Florida Cancer Specialists physicians discuss why teamwork is essential to ensure that oncologic pharmaceuticals are used safely and effectively so that patients achieve optimal clinical outcomes.

Studies conducted by physicians at Florida Cancer Specialists & Research Institute were featured in poster presentations at ASCO 2022 Gastrointestinal Cancers Symposium.

Florida Cancer Specialists & Research Institute provides the newest cancer therapies, some not yet available elsewhere, through convenient access to clinical trials.

Ray Bailey, BPharm, RPh, senior vice president of Pharmacy Services for Florida Cancer Specialists (FCS) Pharmacy Services operations, spoke with The American Journal of Managed Care® (AJMC®) just after the conclusion of the 63rd American Society of Hematology Meeting & Exposition, which took place December 11-14, 2021.

A member of the clinical research team at Florida Cancer Specialists & Research Institute (FCS) served as co-author of a study presented at San Antonio Breast Cancer Symposium.

A member of the clinical research team at Florida Cancer Specialists & Research Institute is to be a first author for a breast cancer study to be presented at San Antonio Breast Cancer Symposium.

Florida Cancer Specialists & Research Institute, LLC (FCS) oncology nurse Brandi Riber, RN, was among the 3 winners of the inaugural Metastatic Breast Cancer Heroes award announced by CURE Media Group.

Debra Patt, MD, PhD, MBA, of Texas Oncology, and Lucio Gordan, MD, of Florida Cancer Specialists, MD, presented data from a study they conducted in partnership with the Community Oncology Alliance and Avalere Health.

Key quality and savings metrics as measured within the most recent performance period from The Centers for Medicare & Medicaid Innovation (CMMI) for the Oncology Care Model (OCM) demonstrated Florida Cancer Specialists & Research Institute as a top performing oncology practice nationwide.

Promotions and additions to the senior leadership team of Florida Cancer Specialists & Research Institute.

Collaboration with community partners recognized for patient care excellence.

Florida Cancer Specialists & Research Institute's (FCS) new state-of-the-art North Port Cancer Center includes new exam rooms, chemotherapy infusion chairs, and PET/CT scan technology.

Three medical oncologists at Florida Cancer Specialists & Research Institute co-author a new integrated safety analysis of umbralisib, used to treat lymphoid malignancies.

Delta variant lowers COVID-19 vaccine effectiveness to 66%; Johnson & Johnson reports booster shot results; cancer center reports mask, vaccine preferences of patients.

Day 1 of this year’s virtual Community Oncology Conference opened with a panel discussion that touched on all things related to the COVID-19 pandemic, with leaders presenting a unified front.

Luis Carrascosa, MD, a radiation oncologist at the Florida Cancer Specialists Ocala Cancer Center, discusses new and upcoming trends in radiation therapy for prostate cancer.

Florida Cancer Specialists has integrated SpaceOAR Hydrogel into its armamentarium as a pre-treatment for radiation therapy in prostate cancer patients.

The COVID-19 pandemic has impacted specialty practices generally and oncology practices especially have been resilient throughout the pandemic.

Nathan H. Walcker will succeed Brad Prechtl on August 1, 2020.